LANXESS to Sell Shares in Envalior by 2026

LANXESS Aktiengesellschaft has announced its intention to exercise its contractual right to offer the sale of its 40.94% stake in Envalior to its joint venture partner, Advent International's investment company, by April 1, 2026. This decision follows the formation of a joint venture with Advent in 2023. The proposed base purchase price for these shares is approximately €1.2 billion, contingent on Envalior's EBITDA performance over the preceding 12 months. Should EBITDA figures deviate significantly, the purchase price will adjust accordingly. If the sale is not concluded in 2026, LANXESS retains options for future sale opportunities in 2027 and 2028 under stipulated conditions.